Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clodronate in hip revision arthroplasty
NCT00658268Phase 2Completed
- Sponsor
- Region Skåne
- Start
- Mar 2008
- Primary completion
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in aseptic loosening of hip prosthesis (AL) comparing Clodronate with Placebo (2 arms). Primary endpoint: Decrease of prosthetic micromotion as measured by RSA at 12 months. Started Mar 2008; status: completed.
02
Drugs
clodronate
03
Conditions
aseptic loosening of hip prosthesis (AL)
Beyond the preview
Go deeper on NCT00658268.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00658268.